JCR Pharmaceuticals Co.,Ltd.
ＪＣＲファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4552
FY2025 · 2026-03-31
| Gross margin | 74.9% |
| Operating margin | 1.4% |
| Net margin | 5.4% |
| Return on equity | 4.8% |
| Return on assets | 2.0% |
| Revenue growth (YoY) | 21.9% |
| EPS (basic) | ¥17.87 |
| EPS growth (YoY) | — |
| Current ratio | 1.16x |
| Equity ratio | 41.8% |
| Book value / share | ¥384.19 |
| Free cash flow | -11,562 M |